NEW YORK (GenomeWeb News) – What has surprised Chris Austin most as he has begun settling into his new job as director of the National Center for Advancing Translational Sciences has been the volume of eager responses the new center has received from people across the biomedical science spectrum.

He has spent much of his time answering emails and calls from "high level people in every arena of the research ecosystem" who want to know what programs NCATS has in the works and how they may be able to get involved.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.